135 related articles for article (PubMed ID: 7996383)
21. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Synergistic Effects of Antimicrobial Peptide Arenicin-1 and Conventional Antibiotics.
Bolosov IA; Kalashnikov AA; Panteleev PV; Ovchinnikova TV
Bull Exp Biol Med; 2017 Apr; 162(6):765-768. PubMed ID: 28429214
[TBL] [Abstract][Full Text] [Related]
23. Combined bactericidal activity of sodium sulphacetamide and cetrimonium bromide.
Yousef RT; Aggag ME; Tawil GG
Pharmazie; 1973 May; 28(5):338-9. PubMed ID: 4197574
[No Abstract] [Full Text] [Related]
24. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal activity of ampicillin and amoxicillin.
Shah PM
J Antimicrob Chemother; 1981 Nov; 8 Suppl C():93-9. PubMed ID: 6798012
[No Abstract] [Full Text] [Related]
26. In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates.
Wilhelm CM; Nunes LS; Martins AF; Barth AL
Diagn Microbiol Infect Dis; 2018 Oct; 92(2):152-154. PubMed ID: 29891185
[TBL] [Abstract][Full Text] [Related]
27. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli.
Kubo A; Lunde CS; Kubo I
Antimicrob Agents Chemother; 1996 Jun; 40(6):1438-41. PubMed ID: 8726016
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus.
Urena MT; Barasoain I; Espinosa M; Garcia E; Portoles A
Chemotherapy; 1975; 21(2):82-9. PubMed ID: 169107
[TBL] [Abstract][Full Text] [Related]
29. [Bactericial activity of chlorhexidine gluconate against recent clinical isolates of various bacterial species in Japan].
Kanazawa K; Ueda Y
Jpn J Antibiot; 2004 Oct; 57(5):449-64. PubMed ID: 15655906
[TBL] [Abstract][Full Text] [Related]
30. Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
El-Sukhon SN; Faiza Boukhatem Z
Int J Antimicrob Agents; 2003 Dec; 22(6):613-7. PubMed ID: 14659660
[TBL] [Abstract][Full Text] [Related]
31. Topical antimicrobial cream sensitivity testing.
Rodeheaver GT; Gentry S; Saffer L; Edlich RF
Surg Gynecol Obstet; 1980 Dec; 151(6):747-52. PubMed ID: 6777888
[TBL] [Abstract][Full Text] [Related]
32. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?
Salvatico S; Feuillolay C; Mas Y; Verrière F; Roques C
Med Mal Infect; 2015 Mar; 45(3):89-94. PubMed ID: 25779009
[TBL] [Abstract][Full Text] [Related]
34. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial action of complexing compounds. The influence of disodium versenate on microorganisms in vitro.
Kośmider S; Rogala D; Kapp-Burzyńska Z
Arch Immunol Ther Exp (Warsz); 1972; 20(6):931-7. PubMed ID: 4197730
[No Abstract] [Full Text] [Related]
36. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
Greco F; Rossi A; De Palma L; Spagnolo N
Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
[TBL] [Abstract][Full Text] [Related]
38. Optimizing breast pocket irrigation: an in vitro study and clinical implications.
Adams WP; Conner WC; Barton FE; Rohrich RJ
Plast Reconstr Surg; 2000 Jan; 105(1):334-8; discussion 339-43. PubMed ID: 10627003
[TBL] [Abstract][Full Text] [Related]
39. [Effects of the most frequently used solutions and ointments in routine surgical practice].
Bravo C; Ondrovcík P; Válka J
Rozhl Chir; 1995 Sep; 74(6):273-6. PubMed ID: 8658275
[TBL] [Abstract][Full Text] [Related]
40. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
Moreira CS; Silva AC; Novais JS; Sá Figueiredo AM; Ferreira VF; da Rocha DR; Castro HC
J Appl Microbiol; 2017 Mar; 122(3):651-662. PubMed ID: 27930849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
